(Q32066343)

6 July 2017

1 reference

title

New agents for the medical treatment of interstitial cystitis (English)

1 reference

6 July 2017

interstitial cystitis

1 reference

Theoharides TC

1

1 reference

PubMed ID

11227050

6 July 2017

Sant GR

series ordinal

2

1 reference

PubMed ID

11227050

6 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

Expert Opinion on Investigational Drugs

6 July 2017

1 reference

6 July 2017

10

1 reference

6 July 2017

3

1 reference

6 July 2017

521-546

1 reference

Interstitial cystitis early diagnosis, pathology, and treatment

6 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Interstitial cystitis in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Altered expression of bladder mast cell growth factor receptor (c-kit) in interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis--a practical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

ATP, pain and a full bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Opiates, mast cells and histamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Anticonvulsant drugs for management of pain: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Central analgesic effects of desipramine, fluvoxamine, and moclobemide after single oral dosing: a study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Desipramine relieves postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Blockade of the flush associated with metastatic gastric carcinoid by combined histamine H1 and H2 receptor antagonists. Evidence for an important role of H2 receptors in human vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Estradiol augments while tamoxifen inhibits rat mast cell secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Cytokine blockade as a new strategy to treat rheumatoid arthritis: inhibition of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Etanercept: a review of its use in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Subtypes of bladder mast cells in interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Urinary excretion of a metabolite of histamine (1,4-methyl-imidazole-acetic-acid) in painful bladder disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Mast cells mediate the severity of experimental cystitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Comparative Cytokine Release from Human Monocytes, Monocyte-Derived Immature Mast Cells, and a Human Mast Cell Line (HMC-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Production of interleukin-6 by human mast cells and basophilic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

The role of mast cells and basophils in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Neurotensin mediates rat bladder mast cell degranulation triggered by acute psychological stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Nerve-mast cell interaction in normal guinea pig urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Distinctive ultrastructural pathology of nonulcerative interstitial cystitis: new observations and their potential significance in pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Cimetidine in the treatment of interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Analgesic effects of antihistaminics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache: a randomized, prospective, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Mast cells in accessory glands of experimentally induced prostatitis in male Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Effect of flavone inhibitors of transport ATPases on histamine secretion from rat mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

ERM (ezrin/radixin/moesin) family: from cytoskeleton to signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Protective effect of heparin on immunologically induced tracheal smooth muscle contraction in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Chondroitin sulphate inhibits connective tissue mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Treatment of interstitial cystitis with intravesical heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Cytochemical localization of hyaluronan in rat and human skin mast cell granules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Efficacy of pentosan polysulfate in the treatment of interstitial cystitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

The effect of acute distension on vasoactive intestinal polypeptide (VIP), neuropeptide Y (NPY) and substance P (SP) immunoreactive nerves in the female rat urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Capsaicin: actions on nociceptive C-fibres and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Impaired nociception and pain sensation in mice lacking the capsaicin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Relief of pain following intravesical capsaicin in patients with hypersensitive disorders of the lower urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Intravesical treatment of overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Blockade of mast cell histamine secretion in response to neurotensin by SR 48692, a nonpeptide antagonist of the neurotensin brain receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Interaction of neurotensin with the substance P receptor mediating histamine release from rat mast cells and the flare in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

CRH and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Drugs used to treat spasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Nitric oxide, a novel biologic messenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

The dual personality of NO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Nitric oxide (NO) and nociceptive processing in the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Effects of L-arginine treatment on symptoms and bladder nitric oxide levels in patients with interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

A randomized double-blind placebo-controlled crossover trial of the efficacy of L-arginine in the treatment of interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Reactive oxygen species generation and histamine release by activated mast cells: modulation by nitric oxide synthase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

The influence of infections on the development and severity of allergic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

The inverse association between tuberculin responses and atopic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Somatostatin analogues suppress the inflammatory reaction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

Somatostatin induces histamine secretion from rat peritoneal mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.3.521

10.1517/13543784.10.3.521

21 January 2018

Identifiers

DOI

1 reference

6 July 2017

1 reference

PubMed ID

11227050